Content focuses on the financial impact of data management systems on drug development, manufacturing, and distribution; the basic computer system life cycle model and the activities and software quality assurance practices in each phase; and the controls and methods necessary to maintain data integrity and security.
Guidance Documents
Advanced Manufacturing (1)
+Artificial Intelligence (1)
+Commissioning & Qualification (1)
+Data Integrity (16)
+GAMP® (14)
+Knowledge Management (1)
+Pharma 4.0™ (1)
+Quality Assurance (1)
+Regulatory (1)
+Validation (11)
+Community Discussions
Community Discussions
May 22, 2025
Apr 24, 2025
Validation
Apr 16, 2025
Information Systems
Regulatory
Advanced Manufacturing
Artificial Intelligence
Apr 08, 2025
Data Integrity
Apr 07, 2025
Advanced Manufacturing
Artificial Intelligence
Pharmaceutical Engineering Magazine Articles
White Papers
January / February 2025
GAMP® is indispensable for safeguarding the safety, quality, and compliance of pharmaceutical…
January / February 2024
Stakeholders across industries are becoming accustomed to using information technology (IT) systems…
March / April 2022
This article aims to refresh information on open-source software (OSS) within regulated computerized…

Webinars
Upcoming
On-Demand
ISPE in the News
Latest
-
Navigating the Horizon: ISPE’s Vision for Tomorrow
-
ISPE Academy: GMP Refresher Certificate Program
-
Startup Raises $5.5M for Precision Glycans
-
EMA Proposes Updates to Guidance for Cell-, Gene-, Tissue-Based Therapies
-
US FDA Issues Draft Guidance for Color Additives in Drugs
-
Dawah Pharma Partners with Egypt for Supplements, Pharma Products Production
-
Made Scientific Expands Cell Therapy Manufacturing Space
-
Fujifilm's Tilburg Site Goes Greener with e-Boiler
-
Automating Bioprocesses Without Sacrificing Flexibility
- ISPE GAMP® Good Practice Guide: Validation and Compliance of Computerized GCP Systems and Data - Good eClinical Practice